Quotient Wealth Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$201K Buy
+1,097
New +$202K 0.01% 360
2024
Q4
Sell
-1,910
Closed -$370K 326
2024
Q3
$370K Sell
1,910
-719
-27% -$150K 0.01% 214
2024
Q2
$609K Sell
2,629
-5,164
-66% -$1.12M 0.02% 153
2024
Q1
$1.68M Sell
7,793
-5,520
-41% -$1.29M 0.06% 85
2023
Q4
$3.45M Buy
+13,313
New +$3.27M 0.13% 70

Other funds holding BIIB

Quotient Wealth Partners's BIIB Position: Q1 2026 in Review

Quotient Wealth Partners opened a new position in Biogen (BIIB) in Q1 2026: 1,097 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #360 among its holdings. This is a return to the name: Quotient Wealth Partners previously reported a position in BIIB as recently as Q3 2024.

Quotient Wealth Partners first reported a position in BIIB in Q4 2023 and has held it in 5 quarters since. The position peaked at $3.45M in Q4 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Quotient Wealth Partners held 1,097 shares of Biogen worth $201K as of Q1 2026.
  • Biogen was a new Quotient Wealth Partners position in Q1 2026.
  • Biogen made up 0.01% of Quotient Wealth Partners's portfolio in Q1 2026, its #360 holding.
  • Quotient Wealth Partners first reported a position in Biogen in Q4 2023 and has held it in 5 quarters since.
  • Quotient Wealth Partners's Biogen position peaked at $3.45M in Q4 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Quotient Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.